1989
DOI: 10.1097/00007890-198908000-00003
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Combination Treatment With Fk506 and Cyclosporine on Survival Time and Vascular Changes in Renal-Allograft-Recipient Dogs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
22
0

Year Published

1989
1989
1997
1997

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 50 publications
(22 citation statements)
references
References 0 publications
0
22
0
Order By: Relevance
“…In contrast, workers at Cambridge University reported unacceptable toxicity including widespread arteritis. 10 However, we 8 and Ochiai et al 11 have shown such vascular lesions to be present in non-immunosuppressed dogs after whole organ transplantation and in dogs treated with other agents including cyclosporin. Arteritis has not been a feature in baboons treated with FK 506 9 or in formal toxicology studies.…”
Section: Introductionmentioning
confidence: 69%
See 1 more Smart Citation
“…In contrast, workers at Cambridge University reported unacceptable toxicity including widespread arteritis. 10 However, we 8 and Ochiai et al 11 have shown such vascular lesions to be present in non-immunosuppressed dogs after whole organ transplantation and in dogs treated with other agents including cyclosporin. Arteritis has not been a feature in baboons treated with FK 506 9 or in formal toxicology studies.…”
Section: Introductionmentioning
confidence: 69%
“…5,6,8,11 Our clinical experience so far has not encouraged such combination therapy. The FK 506 may have increased the toxicity of cyclosporin, possibly by raising its blood concentration.…”
Section: Discussionmentioning
confidence: 99%
“…Vascular damage described as "vasculitis" involving medium-sized arteries in the liver, pancreas, and heart was reported in tacrolimus-treated dogs (93). Work done by our colleagues and others raised doubts about the significance of these findings, as vasculitis was found with equal frequency in control animals (94,95). Studies in rats, baboons, and monkeys treated with tacrolimus (59,96) also were unable to reproduce vasculitis lesions.…”
Section: Acute Microvascular Toxicitymentioning
confidence: 90%
“…Studies in rats, baboons, and monkeys treated with tacrolimus (59,96) also were unable to reproduce vasculitis lesions. Arteriolar-sized renal vessels in rats and dogs treated with tacrolimus develop focal medial necrosis, accumulation of eosinophilic inclusions, and juxtaglomerular transformation but not true arteritis (94,97,98). In our opinion, these arteriolar lesions are similar to those reported with dopaminergic and adrenergic drugs and are adequately explained by intense vasospasm (99,100).…”
Section: Acute Microvascular Toxicitymentioning
confidence: 99%
“…20, 28,29,30,53,54,62,63,65 In February 1989 it was used successfully to salvage 8 of 10 liver allograft recipients suffering intractable rejection despite optimal cydosporinebased immunotherapy. 50 Further use for this indication accrued over 200 patients, and was expanded to include recipients of heart, kidney, lung, and pancreas allografts.…”
Section: Initial Clinical Studies With Tacrolimusmentioning
confidence: 99%